IDXX
IDEXX Laboratories·NASDAQ
--
--(--)
--
--(--)
IDXX fundamentals
IDEXX Laboratories (IDXX) Revenue Breakdown: Q4 2025 Business & Regional Performance
IDEXX Laboratories (IDXX) reported total revenue of 1.09B USD in Q4 2025, with its core business segment Companion Animal Group contributing 91.55%. Regionally, United States remained the largest market, accounting for 61.90% of total revenue. Explore IDEXX Laboratories's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
IDEXX Laboratories (IDXX) reported total revenue of 1.09B USD in Q4 2025, with its core business segment Companion Animal Group contributing 91.55%. Regionally, United States remained the largest market, accounting for 61.90% of total revenue. Explore IDEXX Laboratories's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What factors drove the changes in IDEXX Laboratories's revenue and profit?What is the market's earnings forecast for IDEXX Laboratories next quarter?What does IDEXX Laboratories do and what are its main business segments?Did IDEXX Laboratories beat or miss consensus estimates last quarter?What is IDEXX Laboratories's gross profit margin?What is IDEXX Laboratories's latest dividend and current dividend yield?What guidance did IDEXX Laboratories's management provide for the next earnings period?What were the key takeaways from IDEXX Laboratories's earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
